vs

Side-by-side financial comparison of GREENPOWER MOTOR Co INC. (GP) and UTAH MEDICAL PRODUCTS INC (UTMD). Click either name above to swap in a different company.

UTAH MEDICAL PRODUCTS INC is the larger business by last-quarter revenue ($9.0M vs $7.2M, roughly 1.3× GREENPOWER MOTOR Co INC.). UTAH MEDICAL PRODUCTS INC runs the higher net margin — 28.4% vs -65.6%, a 94.0% gap on every dollar of revenue. On growth, UTAH MEDICAL PRODUCTS INC posted the faster year-over-year revenue change (-1.2% vs -11.5%).

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California. Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing cancer clinics, radiotherapy centers, and medical oncology practices. Varian Medical Systems employs more than 7,100 people at manufacturing sites...

GP vs UTMD — Head-to-Head

Bigger by revenue
UTMD
UTMD
1.3× larger
UTMD
$9.0M
$7.2M
GP
Growing faster (revenue YoY)
UTMD
UTMD
+10.3% gap
UTMD
-1.2%
-11.5%
GP
Higher net margin
UTMD
UTMD
94.0% more per $
UTMD
28.4%
-65.6%
GP

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GP
GP
UTMD
UTMD
Revenue
$7.2M
$9.0M
Net Profit
$-4.7M
$2.6M
Gross Margin
14.6%
58.2%
Operating Margin
27.0%
Net Margin
-65.6%
28.4%
Revenue YoY
-11.5%
-1.2%
Net Profit YoY
-2.1%
-11.6%
EPS (diluted)
$-0.17
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GP
GP
UTMD
UTMD
Q4 25
$9.0M
Q3 25
$9.8M
Q2 25
$10.0M
Q1 25
$9.7M
Q4 24
$7.2M
$9.2M
Q3 24
$5.3M
$10.0M
Q2 24
$3.0M
$10.4M
Q1 24
$11.3M
Net Profit
GP
GP
UTMD
UTMD
Q4 25
$2.6M
Q3 25
$2.6M
Q2 25
$3.0M
Q1 25
$3.0M
Q4 24
$-4.7M
$2.9M
Q3 24
$-4.7M
$3.6M
Q2 24
$-5.4M
$3.5M
Q1 24
$4.0M
Gross Margin
GP
GP
UTMD
UTMD
Q4 25
58.2%
Q3 25
57.1%
Q2 25
56.2%
Q1 25
57.0%
Q4 24
14.6%
58.1%
Q3 24
8.6%
58.0%
Q2 24
7.4%
60.1%
Q1 24
59.7%
Operating Margin
GP
GP
UTMD
UTMD
Q4 25
27.0%
Q3 25
26.6%
Q2 25
32.1%
Q1 25
32.5%
Q4 24
32.0%
Q3 24
33.4%
Q2 24
33.1%
Q1 24
34.2%
Net Margin
GP
GP
UTMD
UTMD
Q4 25
28.4%
Q3 25
26.8%
Q2 25
30.6%
Q1 25
31.3%
Q4 24
-65.6%
31.7%
Q3 24
-87.9%
35.6%
Q2 24
-179.8%
33.2%
Q1 24
34.9%
EPS (diluted)
GP
GP
UTMD
UTMD
Q4 25
$0.80
Q3 25
$0.82
Q2 25
$0.94
Q1 25
$0.92
Q4 24
$-0.17
$0.86
Q3 24
$-0.18
$1.03
Q2 24
$-0.21
$0.98
Q1 24
$1.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GP
GP
UTMD
UTMD
Cash + ST InvestmentsLiquidity on hand
$621.1K
$85.8M
Total DebtLower is stronger
$225.0K
Stockholders' EquityBook value
$2.1M
$119.3M
Total Assets
$37.4M
$122.5M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GP
GP
UTMD
UTMD
Q4 25
$85.8M
Q3 25
$84.3M
Q2 25
$82.2M
Q1 25
$83.3M
Q4 24
$621.1K
$83.0M
Q3 24
$116.9K
$88.5M
Q2 24
$528.3K
$89.2M
Q1 24
$93.8M
Total Debt
GP
GP
UTMD
UTMD
Q4 25
$225.0K
Q3 25
Q2 25
Q1 25
$269.0K
Q4 24
$282.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GP
GP
UTMD
UTMD
Q4 25
$119.3M
Q3 25
$118.3M
Q2 25
$117.5M
Q1 25
$117.0M
Q4 24
$2.1M
$117.4M
Q3 24
$4.2M
$124.2M
Q2 24
$8.6M
$124.1M
Q1 24
$127.7M
Total Assets
GP
GP
UTMD
UTMD
Q4 25
$122.5M
Q3 25
$122.0M
Q2 25
$120.8M
Q1 25
$122.5M
Q4 24
$37.4M
$122.5M
Q3 24
$39.4M
$129.7M
Q2 24
$43.5M
$130.0M
Q1 24
$135.4M
Debt / Equity
GP
GP
UTMD
UTMD
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GP
GP
UTMD
UTMD
Operating Cash FlowLast quarter
$-1.1M
$3.5M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
37.2%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GP
GP
UTMD
UTMD
Q4 25
$3.5M
Q3 25
$3.9M
Q2 25
$2.9M
Q1 25
$4.5M
Q4 24
$-1.1M
$2.9M
Q3 24
$-1.3M
$3.9M
Q2 24
$-3.2M
$2.8M
Q1 24
$5.3M
Free Cash Flow
GP
GP
UTMD
UTMD
Q4 25
$3.4M
Q3 25
$3.9M
Q2 25
$2.8M
Q1 25
$4.3M
Q4 24
$2.9M
Q3 24
$3.8M
Q2 24
$2.7M
Q1 24
$5.3M
FCF Margin
GP
GP
UTMD
UTMD
Q4 25
37.2%
Q3 25
39.2%
Q2 25
28.4%
Q1 25
44.1%
Q4 24
32.0%
Q3 24
37.7%
Q2 24
25.5%
Q1 24
46.3%
Capex Intensity
GP
GP
UTMD
UTMD
Q4 25
1.2%
Q3 25
0.3%
Q2 25
0.5%
Q1 25
1.9%
Q4 24
0.1%
Q3 24
0.9%
Q2 24
1.1%
Q1 24
0.2%
Cash Conversion
GP
GP
UTMD
UTMD
Q4 25
1.36×
Q3 25
1.47×
Q2 25
0.94×
Q1 25
1.47×
Q4 24
1.01×
Q3 24
1.08×
Q2 24
0.80×
Q1 24
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons